Literature DB >> 10049285

Comparison of efficacies of oral levofloxacin and oral ciprofloxacin in a rabbit model of a staphylococcal abscess.

J Fernandez1, J F Barrett, L Licata, D Amaratunga, M Frosco.   

Abstract

Oral levofloxacin was compared to oral ciprofloxacin in a Staphylococcus aureus subcutaneous abscess model in rabbits. Rabbits were surgically prepared with subcutaneous wiffle balls (43 mm in diameter) and allowed to recover for 4 to 6 weeks. Rabbits were infected by direct injection into the capsule with S. aureus ATCC 29213 (5 x 10(5) CFU) and were allowed to remain infected for 8 days before the initiation of anti-infective treatment. Efficacy was determined by assessing the bacterial load within the capsule over a 10-day treatment period. In single-dose pharmacokinetic studies in infected rabbits, similar area under the concentration-time curve/MIC ratios were obtained in the plasma and abscess fluid for levofloxacin at 45 mg/kg of body weight and ciprofloxacin at 200 mg/kg of body weight. Similar efficacies were seen with levofloxacin at 45 mg/kg/day and ciprofloxacin 400 mg/kg/day by day 10. In this model, levofloxacin was significantly more efficacious than ciprofloxacin (P < 0.01).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10049285      PMCID: PMC89178     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  Ciprofloxacin, azlocillin, ceftizoxime and amikacin alone and in combination against gram-negative bacilli in an infected chamber model.

Authors:  D M Bamberger; L R Peterson; D N Gerding; J A Moody; C E Fasching
Journal:  J Antimicrob Chemother       Date:  1986-07       Impact factor: 5.790

2.  Penetration of cefpiramide and cefazolin into peritoneal capsular fluid in rabbits.

Authors:  H Matsui; T Okuda
Journal:  Antimicrob Agents Chemother       Date:  1988-01       Impact factor: 5.191

3.  Factors affecting antimicrobial agents in an anaerobic abscess.

Authors:  F P Tally
Journal:  J Antimicrob Chemother       Date:  1978-07       Impact factor: 5.790

4.  Efficacies of ofloxacin, rifampin, and clindamycin in treatment of Staphylococcus aureus abscesses and correlation with results of an in vitro assay of intracellular bacterial killing.

Authors:  D M Bamberger; B L Herndon; M Dew; R P Chern; H Mitchell; L E Summers; R F Marcus; S C Kim; P R Suvarna
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

5.  Cephalosporin and aminoglycoside concentrations in peritoneal capsular fluid in rabbits.

Authors:  D N Gerding; W H Hall; E A Schierl; R E Manion
Journal:  Antimicrob Agents Chemother       Date:  1976-12       Impact factor: 5.191

6.  Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous doses.

Authors:  S C Chien; M C Rogge; L G Gisclon; C Curtin; F Wong; J Natarajan; R R Williams; C L Fowler; W K Cheung; A T Chow
Journal:  Antimicrob Agents Chemother       Date:  1997-10       Impact factor: 5.191

7.  Azithromycin in an experimental Staphylococcus aureus abscess model.

Authors:  D M Bamberger; B L Herndon; P R Suvarna
Journal:  J Antimicrob Chemother       Date:  1995-05       Impact factor: 5.790

8.  Efficacies of various antimicrobial agents in treatment of Staphylococcus aureus abscesses and correlation with in vitro tests of antimicrobial activity and neutrophil killing.

Authors:  D M Bamberger; M T Fields; B L Herndon
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

9.  Pharmacokinetic profiles of ciprofloxacin after single intravenous and oral doses.

Authors:  J T Lettieri; M C Rogge; L Kaiser; R M Echols; A H Heller
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

10.  In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacin.

Authors:  K P Fu; S C Lafredo; B Foleno; D M Isaacson; J F Barrett; A J Tobia; M E Rosenthale
Journal:  Antimicrob Agents Chemother       Date:  1992-04       Impact factor: 5.191

  10 in total
  7 in total

1.  Testing the mutant selection window hypothesis in vitro and in vivo with Staphylococcus aureus exposed to fosfomycin.

Authors:  Q Mei; Y Ye; Y-L Zhu; J Cheng; X Chang; Y-Y Liu; H-R Li; J-B Li
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-11-26       Impact factor: 3.267

2.  Validation of the mutant selection window hypothesis with fosfomycin against Escherichia coli and Pseudomonas aeruginosa: an in vitro and in vivo comparative study.

Authors:  Ai-Jun Pan; Qing Mei; Ying Ye; Hong-Ru Li; Bao Liu; Jia-Bin Li
Journal:  J Antibiot (Tokyo)       Date:  2016-10-19       Impact factor: 2.649

3.  Pharmacodynamics of levofloxacin and ciprofloxacin in a murine pneumonia model: peak concentration/MIC versus area under the curve/MIC ratios.

Authors:  F Scaglione; J W Mouton; R Mattina; F Fraschini
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

4.  Protection Afforded by Fluoroquinolones in Animal Models of Respiratory Infections with Bacillus anthracis, Yersinia pestis, and Francisella tularensis.

Authors:  Johnny W Peterson; Scott T Moen; Daniel Healy; Jennifer E Pawlik; Joanna Taormina; Jason Hardcastle; John M Thomas; William S Lawrence; Cindy Ponce; Bagram M Chatuev; Bryan T Gnade; Sheri M Foltz; Stacy L Agar; Jian Sha; Gary R Klimpel; Michelle L Kirtley; Tonyia Eaves-Pyles; Ashok K Chopra
Journal:  Open Microbiol J       Date:  2010-06-03

5.  Secreted Gaussia princeps luciferase as a reporter of Escherichia coli replication in a mouse tissue cage model of infection.

Authors:  Mingyu Liu; Christina Blinn; Sarah M McLeod; John W Wiseman; Joseph V Newman; Stewart L Fisher; Grant K Walkup
Journal:  PLoS One       Date:  2014-03-04       Impact factor: 3.240

6.  Relationship between Cefquinome PK/PD Parameters and Emergence of Resistance of Staphylococcus aureus in Rabbit Tissue-Cage Infection Model.

Authors:  Mingpeng Xiong; Xun Wu; Xiaomei Ye; Longfei Zhang; Shuyi Zeng; Zilong Huang; Yuzhi Wu; Jian Sun; Huanzhong Ding
Journal:  Front Microbiol       Date:  2016-06-07       Impact factor: 5.640

Review 7.  Proteinase-nicked IgGs: an unanticipated target for tumor immunotherapy.

Authors:  Robert E Jordan; Xuejun Fan; Georgina Salazar; Ningyan Zhang; Zhiqiang An
Journal:  Oncoimmunology       Date:  2018-07-23       Impact factor: 8.110

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.